Aaron Stonestrom

Aaron Stonestrom, MD (Assistant Professor) is a clinician-scientist specializing in hematologic disorders at an institution with unspecified university affiliation. His clinical focus includes acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and other hematologic malignancies.

• Education: B.S. in Biochemistry/Cell Biology (UC San Diego); MD and PhD from Perelman School of Medicine (University of Pennsylvania)
• Certifications: ABIM (Internal Medicine, Hematology, Medical Oncology)

Research interests center on epigenetics, clonal hematopoiesis, and molecular mechanisms of leukemia. His lab employs gene editing, synthetic biology, and bioinformatics to study hematologic diseases. Key publication themes include:

• 2024: PI3Kγ inhibition in AML
• 2024: High-risk clonal hematopoiesis in nonhematologic cancers
• 2023: MEN1 mutations and menin resistance
• 2022: Clonal dynamics in sickle cell disease

Publications demonstrate expertise in transcriptional regulation, BET protein function, and mitotic bookmarking mechanisms. Collaborative work with institutions like Memorial Sloan Kettering Cancer Center and University of Pennsylvania is evident.